Geisinger Research
@GeisingerRsrch
Followers
2K
Following
1K
Media
279
Statuses
2K
Geisinger Health System. Specialists in patient-centered research, genomics and precision medicine, including the MyCode® Community Health Initiative.
Pennsylvania, USA
Joined October 2016
🚨Check out the next #MyCode Genomic Screening and Counseling Program Grand Rounds. "Update on Actionable Genes for Return" .Presented by: Juliann Savatt, MS, LCGC & Melissa Kelly, MS, LCGC .📅August 11th .🕛 12:00 - 12:45 PM ET.📨stoy1@geisinger.edu for more info.
0
0
1
🚨Check out the next #MyCode Genomic Screening and Counseling Program Grand Rounds "Enzyme Replacement Therapy for Patients with Fabry Disease".Presented by: Gretchen Urban, MS, LCGC, Genetic Counselor II.📅July 14th .🕛12:00-12:45 PM EDT.📨stoy1@geisinger.edu for more info.
0
1
3
Presented by: Adam Buchanan, MS, MPH, CGC- Director of Genomic Medicine and.Christian Adonizio, MD, MLA, MBA, FACP-Physician of Hematology and Medical Oncology. 🗓️June 9, 2025.🕛12:00-12:45 PM EDT.
0
0
0
Join the next #MyCode Genomic Screening and Counseling Program Grand Rounds "Blood-based multi-cancer detection tests: A new surveillance option for individuals at hereditary cancer risk?" 🧵.
1
0
0
Join the next #MyCode 🧬Genomic Screening and Counseling Program Grand Rounds."Caring for TTR+ MyCode Participants: Insights into those Affected and Unaffected by Amyloidosis".Presented by: Cameron Hayes, MS, CGC &.Brendan Carry, MD.🗓️May 12th .🕛12:00-12:45 PM EDT.
0
0
0
ACMG welcomes Christa L. Martin, PhD, FACMG as its new president-elect at #ACMGMtg25. She will serve a two-year term. Read more: @GeisingerHealth @clesemartin
0
3
8
1 in 30 participants had a potentially actionable genomic finding in Geisinger’s MyCode Community Health Initiative from 2013 to 2024.
0
0
0
💡🤔Clinical genetic testing relies on personal or family history limiting identification of those with genetic risk. Genomic screening like #MyCode complements clinical testing to identify more at-risk patients who can benefit from tailored care. 👇.
1
0
1
Want to read more about #MyCode’s experience with genomic screening? 👉
1 in 30 participants had a potentially actionable genomic finding in Geisinger’s MyCode Community Health Initiative from 2013 to 2024.
0
0
1
👀Don’t miss Kristen Yu’s presentation “Frequency of Thoracic Aortic Aneurysm, Dissection, and Premature Coronary Artery Disease in an Unselected Healthcare Population Receiving ACTA2 Results”🫀👩💼 .🗓️Today at 1:45-2pm, Room 502AB #ACMGMtg25.
1
2
3
RT @TheACMG: Dr. Marc S. Williams, ACMG Past President, finds patient's dedication & perseverance remarkable. "It is a privilege to accompa….
0
3
0
0
1
0
A @GeisingerRsrch study presented at last year’s @TheACMG summarizing #MyCode’s experience identifying and disclosing potentially actionable genomic findings to >5,000 biobank participants is now published in @JAMANetworkOpen #ACMGMtg25 👇.
1
0
1
1 in 30 participants had a potentially actionable genomic finding in Geisinger’s MyCode Community Health Initiative from 2013 to 2024.
0
1
3
📢🚨In a recent study led by @savatt_juliann and @MelissaKellyCGC examining #MyCode's experience disclosing genomic results to biobank participants, over 5,000 participants (1 in 30) have received results and nearly 90% were unaware of their risk before screening. More⬇️.
1
0
4
0
1
0
🚀New publication alert❗️. A recent #study published📖 in @MayoProceedings evaluates conditions approved for #medicalcannabis according to the National Academy of Medicine’s Cannabis Report. #GeisingerCPIO
mcpiqojournal.org
To compare the 2017 National Academies of Sciences, Engineering, and Medicine cannabis report to state medical cannabis (MC) laws defining approved qualifying conditions (QC) from 2017 and 2024 and...
0
0
1
📢The MyCode Genomic Screening and Counseling Program Grand Rounds talk on "Multiplexed screening for monogenic conditions and type 1 diabetes risk using genome sequencing: The Early Check experience" Presenter: Heidi Cope, MS, CGC @RTI_Intl .🗓️3/10 @ noon.📨stoy1@geisinger.edu.
0
0
3